Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
drugs
fda
life sciences
2
×
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
akcea therapeutics
alder biopharmaceutical
allergan
alnylam pharmaceuticals
american academy of neurology
amgen
atogepant
biohaven
biotech
bob azelby
boston
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
clinical trials
detroit blog main
detroit top stories
eli lilly
eptinezumab
erenumab
european medicines agency
fremanezumab
galcanezumab
harvard pilgrim health care
hereditary transthyretin amyloidosis
impel neuropharma
indiana blog main
What
drug
2
×
fda
make
2
×
alnylam
approval
approves
arguments
big
cells
class
commercialized
companies
competitors
decades
drugs
ema
employ
europe
follows
gene
harmful
hits
interference
medicine
meeting
method
migraine
mute
neuro
new
oral
potential
protein
rna
rnai
therapies
uses
way
won
year
Language
Current search:
make
×
drug
×
" life sciences "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
